Sotera Health [SHC] vs Thermo Fisher [TMO] Detailed Stock Comparison

Sotera Health Company

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Sotera Health Company wins in 8 metrics, Thermo Fisher Scientific Inc. wins in 11 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sotera Health Company Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) 57.70 25.84 Thermo Fisher Scientific Inc.
Price-to-Book Ratio 7.31 3.31 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio 375.56 82.91 Thermo Fisher Scientific Inc.
PEG Ratio 0.29 2.29 Sotera Health Company
EV/EBITDA 11.50 19.02 Sotera Health Company
Profit Margin (TTM) 6.70% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) 35.75% 17.89% Sotera Health Company
EBITDA Margin (TTM) 35.75% 17.89% Sotera Health Company
Return on Equity 15.42% 13.52% Sotera Health Company
Return on Assets (TTM) 8.18% 5.00% Sotera Health Company
Free Cash Flow (TTM) $149.18M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 27.78% 22.27% Sotera Health Company
Price-to-Sales Ratio (TTM) 3.82 3.86 Sotera Health Company
Enterprise Value $6.36B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 5.47 4.75 Thermo Fisher Scientific Inc.
Gross Profit Margin (TTM) 54.68% N/A N/A
Revenue per Share (TTM) $4 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $0.27 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.88 0.97 Thermo Fisher Scientific Inc.
Short % of Float 5.18% 1.22% Thermo Fisher Scientific Inc.

Sotera Health Company vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

SHC
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sotera Health Company1.96%-1.74%-0.78%-2.74%-9.32%-13.68%
Thermo Fisher Scientific Inc.1.70%3.89%2.45%-6.72%-18.35%-20.01%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sotera Health Company27.78%5.89%-37.69%-37.69%-37.69%-37.69%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Sotera Health Company vs Thermo Fisher Scientific Inc.

MetricSHCTMO
Market Information
Market Cap i$4.44B$174.55B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i2,339,8702,356,220
90 Day Avg. Volume i2,792,1532,071,517
Last Close$15.57$482.03
52 Week Range$10.80 - $19.85$385.46 - $643.99
% from 52W High-21.56%-25.15%
All-Time High$30.38 (Mar 15, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-48.75%-28.31%
Growth Metrics
Quarterly Revenue Growth0.05%0.06%
Quarterly Earnings Growth1.83%0.10%
Financial Health
Profit Margin (TTM) i0.07%0.15%
Operating Margin (TTM) i0.36%0.18%
Return on Equity (TTM) i0.15%0.14%
Debt to Equity (MRQ) i375.5682.91
Cash & Liquidity
Book Value per Share (MRQ)$2.13$141.96
Cash per Share (MRQ)$1.21$8.75
Operating Cash Flow (TTM) i$287.20M$8.29B
Levered Free Cash Flow (TTM) i$236.80M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Sotera Health Company vs Thermo Fisher Scientific Inc.

MetricSHC (Apr 26, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i57.7025.84
Forward P/E i14.8917.16
PEG Ratio i0.292.29
Price to Sales (TTM) i3.823.86
Price to Book (MRQ) i7.313.31
Market Capitalization
Market Capitalization i$4.44B$174.55B
Enterprise Value i$6.36B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i5.474.75
Enterprise to EBITDA i11.5019.02
Risk & Other Metrics
Beta i1.880.97
Book Value per Share (MRQ) i$2.13$141.96

Financial Statements Comparison: Sotera Health Company vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSHC (2025)TMO (2025)
Revenue/Sales i1.16B44.56B
Cost of Goods Sold i518.08M26.32B
COGS % of Revenue i44.5%59.1%
Gross Profit i645.53M18.24B
Gross Margin i55.5%40.9%
Research & Development iN/A1.40B
Operating Income (EBIT) i362.03M8.11B
Operating Margin i31.1%18.2%
EBITDA i507.29M11.86B
EBITDA Margin i43.6%26.6%
Pre-Tax Income i147.51M7.31B
Pre-Tax Income % of Revenue i12.7%16.4%
Income Tax i69.56M547.00M
Income Tax % of Revenue i6.0%1.2%
Net Income (Profit) i77.95M6.72B
Profit Margin i6.7%15.1%

Balance Sheet & Liquidity Metrics

MetricSHC (2025)TMO (2025)
Cash & Equivalents i344.62M9.85B
Total Current Assets i613.41M28.71B
Total Current Assets % of Revenue i52.7%64.4%
Total Current Liabilities i249.58M15.19B
Total Current Liabilities % of Revenue i21.4%34.1%
Long-Term Debt i2.25B35.85B
Long-Term Debt % of Revenue i193.4%80.5%
Total Shareholders Equity i606.04M53.54B
Retained Earnings i-532.09M59.16B
Retained Earnings % of Revenue i-45.7%132.8%
Property, Plant & Equipment i41.32M0

Cash Flow Statement Comparison

MetricSHC (2025)TMO (2025)
Operating Cash Flow i276.60M7.82B
Operating Cash Flow % of Revenue i23.8%17.5%
Capital Expenditures i-138.02M-1.48B
Free Cash Flow i149.18M6.29B
FCF Margin i12.8%14.1%
Debt Repayment i-86.10M-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricSHCTMO
Shares Short i12.81M4.54M
Short Ratio i4.402.38
Short % of Float i5.18%1.22%
Shares Outstanding i284.37M371.62M
Float Shares i191.73M371.07M
% Held by Insiders i2.32%0.17%
% Held by Institutions i85.40%95.23%
% Held by Public i12.28%4.60%

Dividend Analysis & Yield Comparison: Sotera Health Company vs Thermo Fisher Scientific Inc.

MetricSHCTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026